Pharmacology

Action Mechanism of Action Reference
AGONIST FGF1/KLB agonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Non-alcoholic Fatty Liver Disease 2 D065626 ClinicalTrials
Non-alcoholic Fatty Liver Disease 2 D065626 ClinicalTrials
Diabetes Mellitus, Type 2 2 D003924 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297578
FDA SRS P5T1E46W5D